We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$531M
AUM Growth
+$42.3M
Cap. Flow
+$686K
Cap. Flow %
0.13%
Top 10 Hldgs %
66.25%
Holding
96
New
3
Increased
15
Reduced
52
Closed
5

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$4.92M
2
WBA
Walgreens Boots Alliance
WBA
+$4.48M
3
AMGN icon
Amgen
AMGN
+$3.78M
4
INTC icon
Intel
INTC
+$3.76M
5
CVX icon
Chevron
CVX
+$2.77M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$4.65M
2
RKT icon
Rocket Companies
RKT
+$3.85M
3
BABA icon
Alibaba
BABA
+$2.91M
4
QCOM icon
Qualcomm
QCOM
+$2.7M
5
XOM icon
ExxonMobil
XOM
+$2.58M

Sector Composition

Rank Sector Weight
1 Financials 40.09%
2 Healthcare 18.68%
3 Technology 12.74%
4 Energy 11.58%
5 Consumer Staples 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.08T
$188M 35.45%
629,018
+4,133
+0.7% +$1.18M
XOM icon
2
ExxonMobil
XOM
$658B
$39.2M 7.39%
640,801
-41,334
-6% -$2.58M
QCOM icon
3
Qualcomm
QCOM
$172B
$30.9M 5.82%
168,863
-16,878
-9% -$2.7M
KHC icon
4
Kraft Heinz
KHC
$29.2B
$16.9M 3.19%
471,601
-9,534
-2% -$343K
IBM icon
5
IBM
IBM
$217B
$15M 2.82%
111,917
-37,109
-25% -$4.65M
JNJ icon
6
Johnson & Johnson
JNJ
$652B
$14.8M 2.78%
86,248
-232
-0.3% -$38K
GILD icon
7
Gilead Sciences
GILD
$184B
$13.6M 2.57%
187,440
-300
-0.2% -$20.7K
BAC icon
8
Bank of America
BAC
$436B
$12M 2.25%
268,766
-4,071
-1% -$185K
CAH icon
9
Cardinal Health
CAH
$55.2B
$10.6M 2%
205,780
+100,412
+95% +$4.92M
PFE icon
10
Pfizer
PFE
$162B
$10.5M 1.98%
178,326
-3,223
-2% -$160K
OGN icon
11
Organon & Co
OGN
$3.61B
$9.99M 1.88%
328,167
+677
+0.2% +$22.1K
AMGN icon
12
Amgen
AMGN
$239B
$8.99M 1.7%
39,983
+17,892
+81% +$3.78M
COP icon
13
ConocoPhillips
COP
$159B
$8.79M 1.66%
121,736
-475
-0.4% -$34.6K
WBA
14
DELISTED
Walgreens Boots Alliance
WBA
$8.67M 1.63%
166,198
+92,541
+126% +$4.48M
MCK icon
15
McKesson
MCK
$104B
$7.75M 1.46%
31,175
-255
-0.8% -$56K
BABA icon
16
Alibaba
BABA
$288B
$7.37M 1.39%
62,003
-20,002
-24% -$2.91M
HD icon
17
Home Depot
HD
$336B
$7.04M 1.33%
16,952
-285
-2% -$108K
OXY.WS icon
18
Occidental Petroleum Corp Warrants
OXY.WS
$34.5B
$7.02M 1.32%
556,748
+54,055
+11% +$742K
KO icon
19
Coca-Cola
KO
$390B
$6.93M 1.31%
117,062
-251
-0.2% -$14K
RTX icon
20
RTX Corp
RTX
$285B
$6.42M 1.21%
74,567
-2,000
-3% -$174K
FDX icon
21
FedEx
FDX
$80.3B
$6.1M 1.15%
23,596
-75
-0.3% -$18K
INTC icon
22
Intel
INTC
$460B
$5.67M 1.07%
110,038
+73,493
+201% +$3.76M
LOW icon
23
Lowe's Companies
LOW
$119B
$4.81M 0.91%
18,605
-65
-0.3% -$15.5K
LLY icon
24
Eli Lilly
LLY
$1.06T
$4.74M 0.89%
17,160
NTAP icon
25
NetApp
NTAP
$37.6B
$4.64M 0.88%
50,471
-2,041
-4% -$184K

Similar funds

Greylin Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Greylin Investment Management held 96 positions worth $531M, up 8.7% from $488M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Greylin Investment Management's Q4 2021 filing shows 3 new, 15 increased, 52 reduced and 5 closed positions. Its largest new stake was Viatris: 125,231 shares worth $1.69M. The largest sale was IBM, an estimated $4.65M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

  • Greylin Investment Management's largest Q4 2021 buy was Viatris: 125,231 shares worth $1.69M.
  • Greylin Investment Management added most to Cardinal Health in Q4 2021, an estimated $4.92M increase.
  • Greylin Investment Management's biggest Q4 2021 reduction was IBM, cutting an estimated $4.65M.
  • Greylin Investment Management fully exited StoneCo in Q4 2021, selling an estimated $1.13M.
  • Greylin Investment Management's ten largest holdings make up 66% of its $531M portfolio in Q4 2021.
  • Greylin Investment Management opened 3 new positions and closed 5 in Q4 2021.
  • Greylin Investment Management's portfolio value rose 8.7% quarter-over-quarter to $531M.

Based on Greylin Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.